Mesenchymal Stem Cells Induce an Immunosuppressive Microenvironment in Pituitary Tumors
Authors:
- Daniel Marrero-RodriguezDaniel Marrero-Rodriguez
- Victor A Cortes-MoralesVCVictor A Cortes-Morales
- Amayrani Cano-ZaragozaACAmayrani Cano-Zaragoza
- Florencia Martinez-MendozaFMFlorencia Martinez-Mendoza
- Alejandra Chavez-SantoscoyAlejandra Chavez-Santoscoy
- Silvia Hinojosa-AlvarezSHSilvia Hinojosa-Alvarez
- Jesus Hernandez-PerezJHJesus Hernandez-Perez
- Erick Gomez-ApoEGErick Gomez-Apo
- Guadalupe R Fajardo-OrduñaGFGuadalupe R Fajardo-Orduña
- Keiko Taniguchi-PoncianoKTKeiko Taniguchi-Ponciano
- 9 April 2024
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (11) , 2943-2955
Abstract
Context: The tumor microenvironment (TME) includes diverse cellular components such as mesenchymal stem cells (MSCs) and immune cells, among others. MSC have been isolated from different tumors and they favor tumor cell growth; however, their role in pituitary tumors (PTs) remains unknown. Objective: Herein we report the presence of MSCs in 2 adrenocorticotropin (ACTH)-secreting PTs causing Cushing disease (MCU), 2 nonfunctioning adenomas of gonadotrope differentiation (MNF), and 2 nontumoral pituitary glands (MS). Methods: We have analyzed the transcriptomic profiles by RNA sequencing and compared MSCs in terms of their immunosuppressive effects against lymphoid T-cell and macrophage populations by means of cocultures and flow cytometry. Results: Our transcriptomic analysis revealed molecular differences between MSCs derived from nontumoral pituitaries and MSCs derived from PTs. Two distinct subpopulations of MSC emerged: one displaying immunosuppressive properties and the other with increased proproliferative capabilities, regardless of their origin. MSCs derived from ACTH- and nonfunctioning PTs, but not those derived from nontumoral glands, significantly inhibited the proliferation of activated T cells, favored the generation of regulatory T cells, and promoted M2 macrophage polarization. Such immunosuppressive effects were correlated with an upregulation of programmed death ligand 1 and intracellular expression of macrophage colony-stimulating factor (M-CSF) and interleukin-10. Importantly, MSC derived from ACTH-PTs showed a higher immunosuppressive potential than MSC isolated from nonfunctioning tumors. Conclusion: This study demonstrates the presence of at least 2 MSC subpopulations in the pituitary gland and suggests that immunosuppressive effects of MSCs may have important implications in PT growth.Keywords
Funding Information
- Instituto Mexicano del Seguro Social (R-2019-785-052, R-2023-3602-013)
This publication has 42 references indexed in Scilit:
- Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysiseClinicalMedicine, 2022
- In silico analysis of the immunological landscape of pituitary adenomasJournal of Neuro-Oncology, 2020
- Mesenchymal Stem and Stromal Cells Harness Macrophage-Derived Amphiregulin to Maintain Tissue HomeostasisCell Reports, 2020
- Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistanceCellular Oncology, 2018
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapyJournal of Neuro-Oncology, 2018
- Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell SubsetsCell Reports, 2017
- Diagnosis and Treatment of Pituitary AdenomasJAMA, 2017
- Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorderActa Neuropathologica, 2016
- Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activityCytokine, 2015
- Human Placental Mesenchymal Stem Cells (pMSCs) Play a Role as Immune Suppressive Cells by Shifting Macrophage Differentiation from Inflammatory M1 to Anti-inflammatory M2 MacrophagesStem Cell Reviews and Reports, 2013